NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
7 hedge funds and large institutions have $101K invested in NeuroMetrix, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
40% more funds holding
Funds holding: 5 → 7 (+2)
17% more capital invested
Capital invested by funds: $86K → $101K (+$15K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$26.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$10.9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.76K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$196 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$30 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$8K |
NURO Hedge Fund Activity: Q3 2020 in Review
7 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2020, worth a combined $101K — up 17% from $86K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NURO positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Wedbush Securities, adding an estimated $26.9K. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $8K sold.
- 7 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2020, up from 5 in Q2 2020.
- Funds reported $101K of NeuroMetrix, Inc. Common Stock stock for Q3 2020, up 17% quarter-over-quarter.
- 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2020 and 1 closed out, a net change of +2 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2020 was Wedbush Securities, an estimated $26.9K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q3 2020 was Royal Bank of Canada, an estimated $8K sold.
Based on aggregated 13F filings for Q3 2020.